VEGFA and colonic neoplasm: In the present study, we have demonstrated that AST could reduce tumor volume in HCT 116 nude mice xenograft with a concomitant decrease in serum VEGF level, suggesting that AST exerts its anti-tumor effect in colon cancer by targeting VEGF and its associated signaling pathways.